triclosan has been researched along with Disease Models, Animal in 24 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These studies were conducted to investigate the role of dermal exposure to triclosan, an endocrine-disrupting compound, on the hypersensitivity response to ovalbumin (OVA) in a murine model of asthma." | 7.79 | Exposure to triclosan augments the allergic response to ovalbumin in a mouse model of asthma. ( Anderson, KL; Anderson, SE; Franko, J; Hubbs, AF; Kashon, ML; Lukomska, E; Meade, BJ, 2013) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| " These studies were conducted to investigate the role of dermal exposure to triclosan, an endocrine-disrupting compound, on the hypersensitivity response to ovalbumin (OVA) in a murine model of asthma." | 3.79 | Exposure to triclosan augments the allergic response to ovalbumin in a mouse model of asthma. ( Anderson, KL; Anderson, SE; Franko, J; Hubbs, AF; Kashon, ML; Lukomska, E; Meade, BJ, 2013) |
| "Triclosan (TCS) is a high-volume chemical used as an antimicrobial ingredient in more than 2000 consumer products, such as toothpaste, cosmetics, kitchenware, and toys." | 1.48 | A common antimicrobial additive increases colonic inflammation and colitis-associated colon tumorigenesis in mice. ( Bolling, BW; Gu, M; Kim, D; Liu, Z; Martin, DA; Minter, LM; Ozay, EI; Panigrahy, D; Pei, R; Rey, FE; Romano, KA; Sanidad, KZ; Schmidt, B; Song, M; Wang, W; Wang, Y; Xiao, H; Yang, GY; Yang, H; Yang, J; Zhang, G, 2018) |
| "Triclosan is a biocide currently used in a plethora of consumer and medical products that has recently been loaded into a ureteral stent." | 1.33 | Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model. ( Cadieux, PA; Chew, BH; Dejong, K; Denstedt, JD; Knudsen, BE; Reid, G; Rowe, E, 2006) |
| " The absorption rate was determined in rats by histopathology at 7, 28, 56, 63, 70, and 77 days post-implantation." | 1.31 | Physical and functional comparison of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan) with Coated VICRYL* Suture (coated polyglactin 910 suture). ( Jacinto, G; Scalzo, H; Storch, M; Van Lue, S, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 11 (45.83) | 24.3611 |
| 2020's | 5 (20.83) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, H | 1 |
| England, K | 1 |
| am Ende, C | 1 |
| Truglio, JJ | 1 |
| Luckner, S | 1 |
| Reddy, BG | 1 |
| Marlenee, NL | 1 |
| Knudson, SE | 1 |
| Knudson, DL | 1 |
| Bowen, RA | 1 |
| Kisker, C | 1 |
| Slayden, RA | 1 |
| Tonge, PJ | 2 |
| Anderson, JW | 1 |
| Sarantakis, D | 1 |
| Terpinski, J | 1 |
| Kumar, TR | 1 |
| Tsai, HC | 1 |
| Kuo, M | 1 |
| Ager, AL | 1 |
| Jacobs, WR | 1 |
| Schiehser, GA | 1 |
| Ekins, S | 1 |
| Sacchettini, JC | 1 |
| Jacobus, DP | 1 |
| Fidock, DA | 1 |
| Freundlich, JS | 1 |
| Lauinger, IL | 1 |
| Vivas, L | 1 |
| Perozzo, R | 1 |
| Stairiker, C | 1 |
| Tarun, A | 1 |
| Zloh, M | 1 |
| Zhang, X | 1 |
| Xu, H | 1 |
| Franzblau, SG | 1 |
| Pham, DH | 1 |
| Esguerra, CV | 1 |
| Crawford, AD | 1 |
| Maes, L | 1 |
| Tasdemir, D | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Zhang, H | 1 |
| Liu, J | 3 |
| Yang, C | 1 |
| Fu, Y | 1 |
| Xu, J | 1 |
| Liu, Q | 1 |
| Silva Barbosa, AC | 1 |
| Zhou, D | 1 |
| Xie, Y | 1 |
| Choi, YJ | 1 |
| Tung, HC | 1 |
| Chen, X | 1 |
| Xu, M | 1 |
| Gibbs, RB | 1 |
| Poloyac, SM | 1 |
| Liu, S | 1 |
| Yu, Y | 1 |
| Luo, J | 1 |
| Liu, Y | 2 |
| Xie, W | 1 |
| Yueh, MF | 1 |
| He, F | 1 |
| Chen, C | 1 |
| Vu, C | 1 |
| Tripathi, A | 1 |
| Knight, R | 1 |
| Karin, M | 1 |
| Chen, S | 1 |
| Tukey, RH | 1 |
| Shane, HL | 1 |
| Othumpangat, S | 1 |
| Marshall, NB | 2 |
| Blachere, F | 1 |
| Lukomska, E | 3 |
| Weatherly, LM | 1 |
| Baur, R | 1 |
| Noti, JD | 1 |
| Anderson, SE | 3 |
| Yang, H | 1 |
| Wang, W | 1 |
| Romano, KA | 1 |
| Gu, M | 1 |
| Sanidad, KZ | 1 |
| Kim, D | 1 |
| Yang, J | 1 |
| Schmidt, B | 1 |
| Panigrahy, D | 1 |
| Pei, R | 1 |
| Martin, DA | 1 |
| Ozay, EI | 1 |
| Wang, Y | 1 |
| Song, M | 1 |
| Bolling, BW | 1 |
| Xiao, H | 1 |
| Minter, LM | 1 |
| Yang, GY | 1 |
| Liu, Z | 1 |
| Rey, FE | 1 |
| Zhang, G | 1 |
| Ren, Y | 1 |
| Li, Y | 1 |
| Su, L | 1 |
| Zhang, Y | 1 |
| Huang, F | 1 |
| van Kooten, TG | 1 |
| An, Y | 1 |
| Shi, L | 1 |
| van der Mei, HC | 1 |
| Busscher, HJ | 1 |
| Hirota, R | 1 |
| Ohya, Y | 1 |
| Yamamoto-Hanada, K | 1 |
| Fukutomi, Y | 1 |
| Muto, G | 1 |
| Ngatu, NR | 1 |
| Nakamura, T | 1 |
| Nakamura, H | 1 |
| Bayston, R | 1 |
| Ashraf, W | 1 |
| Pelegrin, I | 1 |
| Fowkes, K | 1 |
| Bienemann, AS | 1 |
| Singleton, WGB | 1 |
| Scott, IS | 1 |
| Stec, J | 1 |
| Fomovska, A | 1 |
| Afanador, GA | 1 |
| Muench, SP | 1 |
| Zhou, Y | 1 |
| Lai, BS | 1 |
| El Bissati, K | 1 |
| Hickman, MR | 1 |
| Lee, PJ | 1 |
| Leed, SE | 1 |
| Auschwitz, JM | 1 |
| Sommervile, C | 1 |
| Woods, S | 1 |
| Roberts, CW | 1 |
| Rice, D | 1 |
| Prigge, ST | 1 |
| McLeod, R | 1 |
| Kozikowski, AP | 1 |
| Witorsch, RJ | 1 |
| Nayak, AP | 1 |
| Long, CM | 1 |
| Hettick, JM | 1 |
| Franko, J | 1 |
| Kashon, ML | 1 |
| Anderson, KL | 1 |
| Hubbs, AF | 1 |
| Meade, BJ | 1 |
| Storch, M | 2 |
| Scalzo, H | 1 |
| Van Lue, S | 1 |
| Jacinto, G | 1 |
| Perry, LC | 1 |
| Davidson, JM | 1 |
| Ward, JJ | 1 |
| Cadieux, PA | 1 |
| Chew, BH | 1 |
| Knudsen, BE | 1 |
| Dejong, K | 1 |
| Rowe, E | 1 |
| Reid, G | 1 |
| Denstedt, JD | 1 |
| Marco, F | 1 |
| Vallez, R | 1 |
| Gonzalez, P | 1 |
| Ortega, L | 1 |
| de la Lama, J | 1 |
| Lopez-Duran, L | 1 |
| Hernandez-Richter, T | 1 |
| Schardey, HM | 1 |
| Löhlein, F | 1 |
| Heiss, MM | 1 |
| Redondo-Müller, M | 1 |
| Hammer, C | 1 |
| Schildberg, FW | 1 |
| Surolia, N | 1 |
| Surolia, A | 1 |
| Archer, HG | 1 |
| Barnett, S | 1 |
| Irving, S | 1 |
| Middleton, KR | 1 |
| Seal, DV | 1 |
2 reviews available for triclosan and Disease Models, Animal
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Critical analysis of endocrine disruptive activity of triclosan and its relevance to human exposure through the use of personal care products.
Topics: Animals; Biological Assay; Cosmetics; Disease Models, Animal; Endocrine Disruptors; Female; Humans; | 2014 |
1 trial available for triclosan and Disease Models, Animal
22 other studies available for triclosan and Disease Models, Animal
| Article | Year |
|---|---|
Slow-onset inhibition of the FabI enoyl reductase from francisella tularensis: residence time and in vivo activity.
Topics: Animals; Anti-Bacterial Agents; Crystallography, X-Ray; Disease Models, Animal; Drug Design; Enoyl-( | 2009 |
Novel diaryl ureas with efficacy in a mouse model of malaria.
Topics: Animals; Antimalarials; Benzene Derivatives; Disease Models, Animal; Drug Discovery; Malaria, Falcip | 2013 |
Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target.
Topics: Animals; Antimalarials; Disease Models, Animal; Enzyme Inhibitors; Fatty Acid Synthase, Type II; Hep | 2013 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Triclosan inhibits the growth of Neospora caninum in vitro and in vivo.
Topics: Animals; Brain; Coccidiosis; Coccidiostats; Disease Models, Animal; Enoyl-(Acyl-Carrier-Protein) Red | 2019 |
Inhibition of Estrogen Sulfotransferase (
Topics: Acute Kidney Injury; Animals; Calcitriol; Disease Models, Animal; Enzyme Inhibitors; Female; Gene Ex | 2020 |
Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Fibroblast Growth Factors; Gene Expres | 2020 |
Topical exposure to triclosan inhibits Th1 immune responses and reduces T cells responding to influenza infection in mice.
Topics: Adaptive Immunity; Administration, Topical; Animals; Disease Models, Animal; Female; Health Personne | 2020 |
A common antimicrobial additive increases colonic inflammation and colitis-associated colon tumorigenesis in mice.
Topics: Animals; Anti-Infective Agents; Carcinogenesis; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; | 2018 |
Nanocarriers with conjugated antimicrobials to eradicate pathogenic biofilms evaluated in murine in vivo and human ex vivo infection models.
Topics: Animals; Anti-Infective Agents; Biofilms; Disease Models, Animal; Drug Carriers; Drug Resistance, Ba | 2018 |
Triclosan-induced alteration of gut microbiome and aggravation of asthmatic airway response in aeroallergen-sensitized mice.
Topics: Allergens; Animals; Anti-Infective Agents, Local; Asthma; Disease Models, Animal; Drug Hypersensitiv | 2019 |
An external ventricular drainage catheter impregnated with rifampicin, trimethoprim and triclosan, with extended activity against MDR Gram-negative bacteria: an in vitro and in vivo study.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Catheter-Related Infections; Catheterization; | 2019 |
Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.
Topics: Animals; Antiprotozoal Agents; Caco-2 Cells; Disease Models, Animal; Dose-Response Relationship, Dru | 2013 |
Topical application of the anti-microbial chemical triclosan induces immunomodulatory responses through the S100A8/A9-TLR4 pathway.
Topics: Administration, Topical; Allergens; Animals; Anti-Infective Agents; Antibodies, Blocking; Calgranuli | 2017 |
Exposure to triclosan augments the allergic response to ovalbumin in a mouse model of asthma.
Topics: Administration, Cutaneous; Animals; Anti-Infective Agents; Asthma; Bronchoalveolar Lavage Fluid; Dis | 2013 |
Physical and functional comparison of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan) with Coated VICRYL* Suture (coated polyglactin 910 suture).
Topics: Animals; Anti-Infective Agents, Local; Coated Materials, Biocompatible; Disease Models, Animal; Fema | 2002 |
A 28-day study of the effect of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan) on wound healing in guinea pig linear incisional skin wounds.
Topics: Animals; Anti-Infective Agents, Local; Biomechanical Phenomena; Coated Materials, Biocompatible; Dis | 2002 |
Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model.
Topics: Animals; Anti-Infective Agents, Local; Disease Models, Animal; Drug Delivery Systems; Equipment Desi | 2006 |
Study of the efficacy of coated Vicryl plus antibacterial suture in an animal model of orthopedic surgery.
Topics: Animals; Anti-Infective Agents, Local; Bone Wires; Disease Models, Animal; Orthopedic Procedures; Po | 2007 |
The prevention and treatment of vascular graft infection with a Triclosan (Irgasan)-bonded Dacron graft: an experimental study in the pig.
Topics: Animals; Anti-Infective Agents, Local; Blood Vessel Prosthesis; Disease Models, Animal; Polyethylene | 2000 |
Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.
Topics: Amino Acid Sequence; Animals; Antimalarials; Disease Models, Animal; Enoyl-(Acyl-Carrier-Protein) Re | 2001 |
A controlled model of moist wound healing: comparison between semi-permeable film, antiseptics and sugar paste.
Topics: Aerosols; Animals; Anti-Infective Agents; Anti-Infective Agents, Local; Bandages; Borates; Chlorhexi | 1990 |